Published in Immunology on February 01, 1991
Recombinant human monocyte IL-8 primes NADPH-oxidase and phospholipase A2 activation in human neutrophils. Immunology (1992) 1.15
Cytokine-induced (interleukins-3, -6 and -8 and tumour necrosis factor-beta) activation and deactivation of human neutrophils. Immunology (1992) 0.91
Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils. Br J Pharmacol (1994) 0.90
Impaired interleukin-8-induced degranulation of polymorphonuclear neutrophils from human immunodeficiency virus type 1-infected individuals. Clin Diagn Lab Immunol (1999) 0.88
Priming of the oxidative burst in human neutrophils by physiological agonists or cytochalasin B results from the recruitment of previously non-responsive cells. Immunology (1994) 0.87
Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils. Immunology (1993) 0.78
Granulocyte and granulocyte-macrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release. Immunology (1994) 0.76
The effect of inhibition of leukotriene synthesis on the activity of interleukin-8 and granulocyte-macrophage colony-stimulating factor. Mediators Inflamm (1993) 0.75
Nitrite is produced by elicited but not by circulating neutrophils. Mediators Inflamm (1993) 0.75
Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med (1978) 6.50
Stimulation of neutrophils by tumor necrosis factor. J Immunol (1986) 5.72
Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol (1985) 5.02
Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med (1984) 3.79
Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest (1986) 3.78
Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature (1985) 3.73
Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J Pharmacol Exp Ther (1987) 2.09
A radioimmunoassay for leukotriene B4. Prostaglandins (1982) 1.86
Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals. J Exp Med (1988) 1.79
Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils. J Clin Invest (1988) 1.69
Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J Clin Invest (1986) 1.57
Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes. Biochem Pharmacol (1980) 1.44
The use of prostacyclin in the separation from plasma and washing of human platelets. Prostaglandins (1982) 1.39
The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. J Immunol (1988) 1.33
Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Br J Pharmacol (1988) 1.31
Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187. Immunology (1983) 1.30
PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection. J Lipid Mediat (1992) 1.29
Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes. J Immunol (1987) 1.23
Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan. J Immunol (1985) 1.21
The intracellular retention of newly synthesized platelet-activating factor. J Immunol (1986) 1.17
Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor. Blood (1986) 1.16
Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4. J Clin Invest (1989) 1.11
Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc Natl Acad Sci U S A (1990) 1.05
Granulocyte-macrophage colony-stimulating factor modulates the excitation-response coupling sequence in human neutrophils. J Immunol (1988) 1.03
Parallel inhibition of neutrophil arachidonic acid metabolism and lysosomal enzyme secretion by nordihydroguaiaretic acid. Life Sci (1980) 1.03
Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils. Immunology (1988) 1.02
Stimulation of guanylate cyclase activity and reduction of adenylate cyclase activity by granulocyte-macrophage colony-stimulating factor in human blood neutrophils. J Immunol (1988) 1.00
Stimulus amplification by PAF and LTB4 in human neutrophils. Pharmacol Res Commun (1986) 0.99
Inhibition of rabbit neutrophil lysosomal enzyme secretion, non-stimulated and chemotactic factor stimulated locomotion by nordihydroguaiaretic acid. Life Sci (1980) 0.98
Both recombinant interleukin-1 (beta) and purified human monocyte interleukin-1 prime human neutrophils for increased oxidative activity and promote neutrophil spreading. J Leukoc Biol (1989) 0.97
Human tumour necrosis factor-alpha (TNF-alpha) directly stimulates arachidonic acid release in human neutrophils. Immunology (1990) 0.97
Granulocyte-macrophage colony-stimulating factor (GM-CSF) primes the respiratory burst and stimulates protein biosynthesis in human neutrophils. FEBS Lett (1989) 0.94
Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models. Biochim Biophys Acta (1988) 0.92
Characterization of the priming effects of human granulocyte-macrophage colony-stimulating factor on human neutrophil leukotriene synthesis. Prostaglandins (1988) 0.91
An elevation in the concentration of free cytosolic calcium is sufficient to activate the oxidative burst of granulocytes primed with recombinant human granulocyte-macrophage colony-stimulating factor. J Biol Chem (1989) 0.91
Enhancement of human neutrophil leukotriene synthesis by human granulocyte-macrophage colony-stimulating factor. Agents Actions (1989) 0.89
Phospholipid metabolism and stimulus-response coupling. Biochem Pharmacol (1987) 0.87
Granulocyte-macrophage colony-stimulating factor primes neutrophils by activating a pertussis toxin-sensitive G protein not associated with phosphatidylinositol turnover. J Biol Chem (1989) 0.86
Platelet-activating factor (PAF) acts as an intercellular messenger in the changes of cytosolic free Ca2+ in human neutrophils induced by opsonized particles. FEBS Lett (1989) 0.85
Release of platelet-activating factor and the metabolism of leukotriene B4 by the human neutrophil when studied in a cell superfusion model. J Immunol (1989) 0.85
Effect of granulocyte-macrophage colony-stimulating factor on superoxide production in cytoplasts and intact human neutrophils: role of protein kinase and G-proteins. J Leukoc Biol (1989) 0.84
Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages. Br J Pharmacol (1989) 0.84
Evidence for an intracellular action of platelet-activating factor in bovine cultured aortic endothelial cells. Br J Pharmacol (1989) 0.84
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and opsonization synergistically enhance leukotriene B4 (LTB4) synthesis induced by phagocytosis in human neutrophils. Agents Actions (1989) 0.82
The role of PAF in immunological responses: a review. Prostaglandins (1987) 0.80
Regulation of cellular retention of paf-acether by extracellular pH and cell concentration. Biochim Biophys Acta (1989) 0.76
How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol (1996) 7.12
Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med (1993) 4.30
Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci (2001) 4.01
Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology (2003) 3.99
Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest (1986) 3.78
Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol (1985) (1997) 3.63
Measuring fitness in healthy older adults: the Health ABC Long Distance Corridor Walk. J Am Geriatr Soc (2001) 3.39
Weight change in old age and its association with mortality. J Am Geriatr Soc (2001) 3.26
Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci (2000) 3.20
Self-reported causes of physical disability in older people: the Cardiovascular Health Study. CHS Collaborative Research Group. J Am Geriatr Soc (1994) 3.05
Tension pneumothorax--time for a re-think? Emerg Med J (2005) 2.80
Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology (2002) 2.68
HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA (1995) 2.46
Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood (1986) 2.45
Body mass index, weight change, and risk of mobility disability in middle-aged and older women. The epidemiologic follow-up study of NHANES I. JAMA (1994) 2.38
Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc (1999) 2.31
The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci (1997) 2.27
Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood (1986) 2.26
The association of bone mineral density and depression in an older population. J Am Geriatr Soc (2001) 2.20
Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE) J Am Geriatr Soc (1996) 2.17
Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab (1998) 2.14
Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax (2005) 2.08
State scholarship, loan forgiveness, and related programs: the unheralded safety net. JAMA (2000) 2.03
Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. Ann Emerg Med (1998) 2.02
Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3. Proc Natl Acad Sci U S A (1987) 1.89
Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med (1997) 1.85
Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies. Br J Haematol (1984) 1.80
Social support, self-esteem and depression. Psychol Med (1986) 1.73
Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. J Exp Med (1986) 1.73
Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils. J Clin Invest (1988) 1.69
Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology (2011) 1.69
London bombings July 2005: the immediate pre-hospital medical response. Resuscitation (2005) 1.67
Loss of parent in childhood and adult psychiatric disorder: the role of lack of adequate parental care. Psychol Med (1986) 1.64
Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood (1997) 1.63
Befriending as an intervention for chronic depression among women in an inner city. 1: Randomised controlled trial. Br J Psychiatry (1999) 1.61
Neonatal genital prolapse. Pediatrics (1992) 1.60
Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med (2003) 1.59
Depression and loss. Br J Psychiatry (1977) 1.58
Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors. J Immunol (1983) 1.54
Acute otitis media in children. BMJ (1997) 1.54
Evidence for inflammation as a cause of hypocholesterolemia in older people. J Am Geriatr Soc (1995) 1.49
Age, gender, and race/ethnic differences in total body and subregional bone density. Osteoporos Int (2008) 1.46
Mononuclear cell-mediated enhancement of granulocyte function in man. J Immunol (1984) 1.42
Aging bone in men and women: beyond changes in bone mineral density. Osteoporos Int (2003) 1.39
Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol Aging (2006) 1.38
Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells (1998) 1.37
Identification of a novel integrin beta subunit expressed on cultured monocytes (macrophages). Evidence that one alpha subunit can associate with multiple beta subunits. J Biol Chem (1990) 1.36
Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol (1994) 1.36
The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Arch Dis Child (2004) 1.32
Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Br J Pharmacol (1988) 1.31
Location specific radiographic joint space width for osteoarthritis progression. Osteoarthritis Cartilage (2008) 1.31
Eosinophils and not lymphoid K cells kill Trypanosoma cruzi epimastigotes. Nature (1977) 1.30
Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J Neurol Neurosurg Psychiatry (1989) 1.29
Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk. Int J Obes (Lond) (2007) 1.28
Social origins of depression: a reply. Psychol Med (1978) 1.28
Difficulty with holding urine among older persons in a geographically defined community: prevalence and correlates. J Am Geriatr Soc (1995) 1.26
Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology (1999) 1.24
Anthropometric indicators and hip fracture. The NHANES I epidemiologic follow-up study. J Am Geriatr Soc (1989) 1.24
Pelvic body composition measurements by quantitative computed tomography: association with recent hip fracture. Bone (2008) 1.23
Patella malalignment, pain and patellofemoral progression: the Health ABC Study. Osteoarthritis Cartilage (2007) 1.23
The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos Int (2007) 1.19
The vacuolar ATPase of Neurospora crassa contains an F1-like structure. J Biol Chem (1989) 1.17
Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood (1996) 1.17
The Cardiff sib-pair study: suicidal ideation in depressed and healthy subjects and their siblings. Crisis (2001) 1.16
Prevention in practice: results of a 2-year follow-up of routine health promotion interventions in general practice. Fam Pract (1996) 1.15
Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-alpha mutants. EMBO J (1994) 1.15
Effects of age on body fat distribution and cardiovascular risk factors in women. Am J Clin Nutr (1997) 1.15
Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol (1999) 1.14
Weight loss from maximum body weight among middle-aged and older white women and the risk of hip fracture: the NHANES I epidemiologic follow-up study. Osteoporos Int (2001) 1.14
Correlates of performance-based measures of muscle function in the elderly: the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci (1997) 1.13
CNS tuberculosis: a longitudinal analysis of epidemiological and clinical features. Int J Tuberc Lung Dis (2006) 1.12
Intravenous ketamine for pediatric sedation in the emergency department: safety profile with 156 cases. Acad Emerg Med (1998) 1.12
Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: the health, aging, and body composition study. Calcif Tissue Int (2006) 1.12
IL-3 and granulocyte-macrophage colony-stimulating factor stimulate two distinct phases of adhesion in human monocytes. J Immunol (1990) 1.12
Finding function through structural genomics. Curr Opin Biotechnol (2000) 1.11
Neutrophils activated by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression. Blood (1995) 1.11
Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. Mol Cell (2000) 1.10
Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor. Blood (1987) 1.10
The burden and outcomes associated with dehydration among US elderly, 1991. Am J Public Health (1994) 1.09
Diagnosis of growth hormone deficiency in adults. Lancet (1994) 1.08
Granulocyte-macrophage colony-stimulating factor is a stimulant of platelet-activating factor and superoxide anion generation by human neutrophils. J Biol Chem (1991) 1.08
Structure-function studies of human granulocyte-macrophage colony-stimulating factor. Identification of residues required for activity. J Immunol (1988) 1.07
Validity of retrospective diet history: assessing recall of midlife diet using food frequency questionnaire in later life. J Nutr Health Aging (2011) 1.06
Hip fracture rates in Hong Kong and the United States, 1988 through 1989. Am J Public Health (1993) 1.06
Depression of immunity to Naegleria fowleri in mice by selective depletion of neutrophils with a monoclonal antibody. Infect Immun (1988) 1.06
Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care (1999) 1.06
Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3ζ deficiency. Mol Psychiatry (2011) 1.06
Interleukin 4 is at 5q31 and interleukin 6 is at 7p15. Hum Genet (1988) 1.05
A model for the interaction of the GM-CSF, IL-3 and IL-5 receptors with their ligands. Growth Factors (1993) 1.05
Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitors. Leukemia (2010) 1.05
Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc Natl Acad Sci U S A (1990) 1.05
Transferability and fine-mapping of glucose and insulin quantitative trait loci across populations: CARe, the Candidate Gene Association Resource. Diabetologia (2012) 1.03
Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils. Immunology (1988) 1.02